Incanthera PLC (AQSE:INC) has raised £508,000 to speed up the launch of its Skin + CELL skincare line. The funds will back an August rollout and a big marketing push with influencers.
Faron Pharmaceuticals Limited (AIM:FARN) has unveiled research showing its bexmarilimab therapy can lower levels of a molecule that helps cancer hide from the immune system. The findings could make bexmarilimab a key tool for hard-to-treat cancers.
hVIVO PLC (AIM:HVO) has completed work on a big flu prevention study of Cidara’s CD388 drug. The trial hit its goals, with the highest dose cutting flu-like illness rates to less than 1%.
Powerhouse Energy Group PLC (AIM:PHE) said Engsolve has finished the engineering design for a hydrogen project in Australia. The plan now moves to permitting and financing.
CleanTech Lithium PLC (AIM:CTL, OTCQX:CTLHF) will enter a public tender after losing its bid to fast-track a lithium contract in Chile. The company remains confident given its early investment and local agreements.
ACG Metals Ltd (LSE:ACG, OTC:ACGAF) has appointed Peter Carter as chief operating officer to lead operations at its Gediktepe mine in Turkey. Carter brings four decades of mining experience and will help steer expansion plans.
Follow us and subscribe on YouTube, our social channels and on proactiveinvestors.co.uk.
